SEP 15·SEC EDGARLow
Yu Jeffrey purchased $90K of ONMD
Yu Jeffrey (Chief Medical Officer) purchased 142,857 shares of OneMedNet Corp (ONMD) at $0.63 on 2026-09-10.
StockNASDAQ · US · USDHealthcare · Health Information Services
$ONMD
OneMedNet Corp
Price · $ONMDvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $ONMD in the last 7 days.
Insider · 30dAll trades →
- Buys
- $90K 1 txs
- Sells
- — 0 txs
Yu Jeffrey1× · $90K
10b5-1 share of filings0%
Top stories · $ONMDMore →
AUG 7·SEC EDGAR
Kosasa Thomas purchased $1,000K of ONMD
Kosasa Thomas purchased 1,449,275 shares of OneMedNet Corp (ONMD) at $0.69 ($1.00M total) on 2026-07-30.
JUL 1·SEC EDGAR 8-K
OneMedNet Corp (ONMD): Entry into a Material Definitive Agreement
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “ Agreement ”) dated as of July 1, 2026 is made by and between YA II PN, LTD. , a Cayman Islands exempt limited company (the “ Investor ”), and ONEMEDNET CORPO
ONMD sentiment & insider activity
Recent ONMD coverage spans insider activity, corporate actions and market movers.
In the last 30 days, ONMD insiders filed 1 SEC Form 4 transaction — 1 purchase ($90K) and no sales. The most active reporter was Yu Jeffrey, Chief Medical Officer, with 1 filing.
What's driving ONMD
Insider purchase signals confidence from senior management, modestly bullish for the stock.
Insider buying is a modest bullish signal, but it is not a fundamental catalyst like guidance, contracts, or trial results.
The filing discloses a new equity financing mechanism (standby purchase agreement) that can increase dilution over time depending on drawdowns.
A CEO open-market buy is a modest insider signal, but the disclosed dollar amount is small and lacks a 10b5-1 context.
Insider buying is a modest sentiment signal, but it is not a fundamental catalyst by itself.
AlphAI scores every news story that mentions ONMD with an AI model for sentiment and relevance, and aggregates insider trades from OneMedNet Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $ONMD
Score
Yu Jeffrey purchased $90K of ONMD
Yu Jeffrey (Chief Medical Officer) purchased 142,857 shares of OneMedNet Corp (ONMD) at $0.63 on 2026-09-10.
1 min readKosasa Thomas purchased $1,000K of ONMD
Kosasa Thomas purchased 1,449,275 shares of OneMedNet Corp (ONMD) at $0.69 ($1.00M total) on 2026-07-30.
2 min readOneMedNet Corp (ONMD): Entry into a Material Definitive Agreement
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “ Agreement ”) dated as of July 1, 2026 is made by and between YA II PN, LTD. , a Cayman Islands exempt limited company (the “ Investor ”), and ONEMEDNET CORPO
4 min readGreen Aaron purchased $21K of ONMD
Green Aaron (Chief Executive Officer) purchased 36,650 shares of OneMedNet Corp (ONMD) at $0.57 on 2026-06-23.
2 min readYu Jeffrey purchased $100K of ONMD
Yu Jeffrey (Chief Medical Officer) purchased 158,730 shares of OneMedNet Corp (ONMD) at $0.63 on 2026-06-23.
2 min readYu Jeffrey purchased $100K of ONMD
Yu Jeffrey (Chief Medical Officer) purchased 172,414 shares of OneMedNet Corp (ONMD) at $0.58 ($0.10M total) on 2026-06-16.
1 min readGreen Aaron purchased $31K of ONMD
Green Aaron (Chief Executive Officer) purchased 55,622 shares of OneMedNet Corp (ONMD) at an average of $0.55 ($0.54–$0.56) across 2 trades over 2026-06-12 to 2026-06-15.
2 min readKosasa Thomas purchased $100K of ONMD
Kosasa Thomas purchased 158,730 shares of OneMedNet Corp (ONMD) at $0.63 on 2026-06-12.
1 min read
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
OneMedNet Corp. (Nasdaq: ONMD) said it secured more than $3 million in new bookings for 2026 as of June 10, exceeding full-year 2025 bookings, and expects substantially all to convert to revenue by end of Q3 2026, according to the company. Growth is tied to demand for regulatory-grade multi-modal real-world data via its iRWD platform.
4 min read
OneMedNet Completes Strategic Pivot Following SPAC Merger
OneMedNet has finalized its SPAC merger with Data Knights Acquisition Corp. and is now listed on Nasdaq as ONMD. The company has shifted its focus entirely to providing curated medical imaging data for research purposes. Despite facing capital constraints due to significant shareholder redemptions post-merger, OneMedNet aims to grow its presence in the Real-World Data market to support medical research and development.
3 min read